Cannabis and Real World Data with Dr. Miyabe Shields

Dr. Riley Kirk welcomes Dr. Miyabe Shields for a deep dive into cannabis real-world data, cannabis consumption patterns, dosing, neurodivergent cannabis use, and the Endocannabinoid System (ECS). As co-founders of the Network of Applied Pharmacognosy (NAP), Riley and Miyabe discuss the newly accessible Real Data Project, including what large-scale consumer data can reveal about how people actually use cannabis in their everyday lives.

They explore why terms like “heavy cannabis consumption” are difficult to define, how consumption can vary by dose and frequency, and what the data shows across different populations and consumption methods. They also discuss the importance of making real-world cannabis data accessible to consumers, researchers, patients, and healthcare professionals rather than keeping it behind academic paywalls or within highly controlled research settings.

The conversation also covers cannabis and neurodivergence, cannabis and mental health, the challenges of interpreting cannabis research, product chemistry and consumer experiences, terpene levels, cannabis aging, and how chemical data can eventually be connected with the way individual consumers actually feel after using a product.

Finally, Riley and Miyabe discuss their ECS-focused e-book, created to make information about the Endocannabinoid System more accessible to both new and experienced cannabis consumers, including practical information about dosing, lifestyle, sleep, exercise, diet, and understanding your own ECS.

Chapters

00:00 Giveaway!

00:53 Welcome to another NAP Time episode

01:27 What is the Real Data Project?

03:00 Why “heavy cannabis consumption” is difficult to define

04:25 Dose, frequency, and different types of cannabis consumers

06:05 What the consumption data is beginning to reveal

09:20 Real-world data on cannabis-infused beverages